[Federal Register: December 11, 1995 (Volume 60, Number 237)]
[Notices]
[Page 63499]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr11de95-35]
=======================================================================
-----------------------------------------------------------------------
[[Page 63499]]
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[Order No. 787]
IPR Pharmaceuticals, Inc., (Pharmaceutical Products), Guayama and
Carolina, Puerto Rico; Grant of Authority for Subzone Status
Pursuant to its authority under the Foreign-Trade Zones Act of
June 18, 1934, as amended (19 U.S.C. 81a-81u), the Foreign-Trade
Zones Board (the Board) adopts the following Order:
Whereas, by an Act of Congress approved June 18, 1934, an Act ``To
provide for the establishment * * * of foreign-trade zones in ports of
entry of the United States, to expedite and encourage foreign commerce,
and for other purposes,'' as amended (19 U.S.C. 81a-81u) (the Act), the
Foreign-Trade Zones Board (the Board) is authorized to grant to
qualified corporations the privilege of establishing foreign-trade
zones in or adjacent to U.S. Customs ports of entry;
Whereas, the Board's regulations (15 CFR Part 400) provide for the
establishment of special-purpose subzones when existing zone facilities
cannot serve the specific use involved;
Whereas, an application from the Commercial and Farm Credit and
Development Corporation of Puerto Rico, grantee of Foreign-Trade Zone
61, for authority to establish special-purpose subzone status at the
pharmaceutical manufacturing facilities of IPR Pharmaceuticals, Inc.,
in Guayama and Carolina, Puerto Rico, was filed by the Board on
December 16, 1994, and notice inviting public comment was given in the
Federal Register (FTZ Docket 42-94, 59 FR 66892, 12-28-94); and,
Whereas, the Board has found that the requirements of the FTZ Act
and Board's regulations are satisfied, and that approval of the
application is in the public interest;
Now, therefore, the Board hereby authorizes the establishment of
subzones (Subzones 61F and 61G) at the plant sites of IPR
Pharmaceuticals, Inc., in Guayama and Carolina, at the locations
described in the application, subject to the FTZ Act and the Board's
regulations, including Sec. 400.28.
Signed at Washington, DC, this 28th day of November 1995.
Susan G. Esserman,
Assistant Secretary of Commerce for Enforcement and Compliance, Alternate
Chairman, Foreign-Trade Zones Board.
ATTEST:
John J. Da Ponte, Jr.,
Executive Secretary.
[FR Doc. 95-30091 Filed 12-8-95; 8:45 am]
BILLING CODE 3510-DS-P